- Home
- VNET vs APGE Comparison
VNET vs APGE Comparison
Compare VNET & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- APGE
- Stock Information
- Founded
- VNET 1999
- APGE 2022
- Country
- VNET China
- APGE United States
- Employees
- VNET N/A
- APGE N/A
- Industry
- VNET Computer Software: Programming Data Processing
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VNET Technology
- APGE Health Care
- Exchange
- VNET Nasdaq
- APGE Nasdaq
- Market Cap
- VNET 2.1B
- APGE 2.0B
- IPO Year
- VNET 2011
- APGE 2023
- Fundamental
- Price
- VNET $9.49
- APGE $37.80
- Analyst Decision
- VNET Strong Buy
- APGE Strong Buy
- Analyst Count
- VNET 4
- APGE 5
- Target Price
- VNET $11.20
- APGE $95.40
- AVG Volume (30 Days)
- VNET 6.3M
- APGE 473.0K
- Earning Date
- VNET 08-21-2025
- APGE 11-11-2025
- Dividend Yield
- VNET N/A
- APGE N/A
- EPS Growth
- VNET N/A
- APGE N/A
- EPS
- VNET N/A
- APGE N/A
- Revenue
- VNET $1,262,962,115.00
- APGE N/A
- Revenue This Year
- VNET $15.46
- APGE N/A
- Revenue Next Year
- VNET $20.35
- APGE N/A
- P/E Ratio
- VNET $419.61
- APGE N/A
- Revenue Growth
- VNET 17.85
- APGE N/A
- 52 Week Low
- VNET $2.68
- APGE $26.20
- 52 Week High
- VNET $16.13
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- VNET 64.23
- APGE 50.37
- Support Level
- VNET $7.68
- APGE $36.81
- Resistance Level
- VNET $8.34
- APGE $38.84
- Average True Range (ATR)
- VNET 0.58
- APGE 1.53
- MACD
- VNET 0.13
- APGE 0.11
- Stochastic Oscillator
- VNET 94.21
- APGE 64.72
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2025, it had 51,960 retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 674 MW of wholesale capacity in service with a further 326 MW under construction and a further 792 MW held for future development.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.